Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
Hong Kong · Delayed Price · Currency is HKD 2.430
-0.170 (-6.54%)
Jun 17, 2026, 4:08 PM HKT
HKG:2185 Market Cap
HKG:2185 has a market cap or net worth of 591.5 million as of June 17, 2026. Its market cap has decreased by -6.18% in one year.
Market Cap
591.50M
Enterprise Value
526.39M
Revenue
50.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.43
Market Cap Chart
Since December 23, 2021, HKG:2185's market cap has decreased from 4.90B to 591.50M, a decrease of -87.94%. That is a compound annual growth rate of -37.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 591.50M | -58.03% |
| Dec 31, 2025 | 1.41B | 253.05% |
| Dec 31, 2024 | 399.20M | -52.05% |
| Dec 29, 2023 | 832.49M | -41.56% |
| Dec 30, 2022 | 1.42B | -78.41% |
| Dec 31, 2021 | 6.60B | 34.58% |
| Dec 23, 2021 | 4.90B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 1.16B |
| Cloudbreak Pharma | 1.04B |
| Sunho Biologics | 970.43M |
| Wuhan YZY Biopharma | 814.17M |
| Brii Biosciences | 729.03M |
| JW (Cayman) Therapeutics Co. | 694.08M |
| 3D Medicines | 676.28M |
| Transcenta Holding | 597.30M |